SCHEMBL7666243

SCHEMBL7666243

COc1ccc(C(=O)Nc2ccc(-c3ccc(NC(=O)c4ccc(OC)c(S(=O)(=O)N5CCOCC5)c4)cc3S(=O)(=O)O)c(S(=O)(=O)O)c2)cc1S(=O)(=O)N1CCOCC1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.73
KMT2A Q03164 6/20 0.72
ALDH1A1 P00352 5/20 0.72
MAPK1 P28482 4/20 0.72
LMNA P02545 4/20 0.72
MEN1 O00255 4/20 0.72
HSD17B10 Q99714 4/20 0.72
KDM4E B2RXH2 3/20 0.72
SMN1; SMN2 Q16637 2/20 0.72
TSHR P16473 1/20 0.72
GAA P10253 1/20 0.72
NPSR1 Q6W5P4 2/20 0.66
MAPT P10636 2/20 0.66
USP2 O75604 1/20 0.66
CA1 P00915 1/20 0.65
CA2 P00918 1/20 0.65
HTT P42858 1/20 0.65
CYP2D6 P10635 1/20 0.63
CYP2C9 P11712 1/20 0.63
CYP2C19 P33261 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7663896 0.91 ALDH1A1 (0.72) L3MBTL1KMT2AALDH1A1MAPK1LMNA
SCHEMBL7666465 0.90 KMT2A (0.68) L3MBTL1KMT2AALDH1A1MAPK1LMNA
SCHEMBL7666544 0.90 KMT2A (0.68) L3MBTL1KMT2AALDH1A1MAPK1LMNA
SCHEMBL7664936 0.90 KMT2A (0.68) L3MBTL1KMT2AALDH1A1MAPK1LMNA
SCHEMBL7663221 0.88 ALDH1A1 (0.69) L3MBTL1KMT2AALDH1A1MAPK1LMNA
SCHEMBL7664872 0.87 ALDH1A1 (0.68) L3MBTL1KMT2AALDH1A1MAPK1LMNA
SCHEMBL7675932 0.86 MEN1 (0.81) L3MBTL1KMT2AALDH1A1MAPK1LMNA
SCHEMBL7665092 0.85 LMNA (0.67) L3MBTL1KMT2AALDH1A1MAPK1LMNA
SCHEMBL26014150 0.85 SMN1; SMN2 (0.89) L3MBTL1KMT2AALDH1A1MAPK1LMNA
SCHEMBL7658982 0.84 LMNA (0.64) L3MBTL1KMT2AALDH1A1MAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020111369-A1 Aryl sulfonic acids and derivatives as FSH antagonists AMERICAN HOME PRODUCTS CORPORATION (US) 2002-08-15 US claimed
WO-2000058277-A1 ARYL SULFONIC ACIDS AND DERIVATIVES AS FSH ANTAGONISTS AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-05 WO claimed
US-20020111369-A1 Aryl sulfonic acids and derivatives as FSH antagonists AMERICAN HOME PRODUCTS CORPORATION (US) 2002-08-15 US disclosed
US-6355633-B1 CONTRACEPTIVES AMERICAN HOME PRODUCTS CORPORATION 2002-03-12 US disclosed
WO-2000058277-A1 ARYL SULFONIC ACIDS AND DERIVATIVES AS FSH ANTAGONISTS AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020111369-A1 Aryl sulfonic acids and derivatives as FSH antagonists FSHR, GNRHR, LHCGR L3MBTL1 4076/4885KMT2A 1116/4885ALDH1A1 3990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.